| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 15 |
| 1 | CAPECITABINE | 12 |
| 2 | TRASTUZUMAB | 11 |
| 3 | CISPLATIN | 7 |
| 4 | APREPITANT | 6 |
| 5 | FLUOROURACIL | 6 |
| 6 | FLUOROURACIL CREAM, 0.5% | 6 |
| 7 | MAGNESIUM OXIDE | 6 |
| 8 | DEXAMETHASONE SODIUM PHOSPHATE | 4 |
| 9 | ESOMEPRAZOLE MAGNESIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZANIDATAMAB-HRII | 1 | 0.0122 |
| 1 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 2 | FUTIBATINIB | 1 | 0.0045 |
| 3 | BODY CLEANSER | 1 | 0.0014 |
| 4 | NALDEMEDINE | 2 | 0.0012 |
| 5 | APREPITANT | 6 | 0.0008 |
| 6 | SENNOSIDES A AND B | 1 | 0.0006 |
| 7 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 8 | DEXAMETHASONE SODIUM PHOSPHATE | 4 | 0.0004 |
| 9 | SKIN PROTECTANT | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific HER2-directed Antibody [EPC] | 1 | 0.0122 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 11 | 0.0001 |
| 4 | Bile Acid [EPC] | 2 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 19 | 0.0001 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 18 | 0.0001 |
| 7 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 2 | 0.0000 |